Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
146.4 GBX | 0.00% | 0.00% | 0.00% |
May. 15 | This bodes well for rate cuts | |
May. 15 | Barclays Lowers Centrica PT, Maintains Overweight Rating | MT |
Sales 2024 * | 23.67B 30.05B | Sales 2025 * | 20.8B 26.4B | Capitalization | 7.61B 9.66B |
---|---|---|---|---|---|
Net income 2024 * | 930M 1.18B | Net income 2025 * | 729M 925M | EV / Sales 2024 * | 0.21 x |
Net cash position 2024 * | 2.74B 3.48B | Net cash position 2025 * | 2.7B 3.42B | EV / Sales 2025 * | 0.24 x |
P/E ratio 2024 * |
8.11
x | P/E ratio 2025 * |
10.8
x | Employees | - |
Yield 2024 * |
3.25% | Yield 2025 * |
3.79% | Free-Float | 91.42% |
Latest transcript on Centrica plc
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 50 | 18-10-31 | |
Russell O'Brien
DFI | Director of Finance/CFO | - | 23-02-28 |
Alex Hughes
IRC | Investor Relations Contact | - | 22-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jonathan Wheway
CHM | Chairman | 57 | 16-04-30 |
Kevin O'Byrne
BRD | Director/Board Member | 59 | 19-05-12 |
Nathan Bostock
BRD | Director/Board Member | 63 | 22-05-08 |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+83.64% | 92.82B | |
-17.14% | 88.76B | |
+7.18% | 53.71B | |
-.--% | 51.55B | |
+4.56% | 49.47B | |
-0.93% | 41.52B | |
+21.91% | 37.13B | |
-15.10% | 28.07B | |
+7.42% | 23.83B |
- Stock Market
- Equities
- CNA Stock
- CNA Stock